ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)
CNY 8.56
(2.27%)
CNY 8.56
(2.27%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 120.83 Million CNY | 17.02% |
| 2022 | 103.25 Million CNY | -4.73% |
| 2021 | 108.38 Million CNY | -11.48% |
| 2020 | 122.43 Million CNY | -6.56% |
| 2019 | 131.03 Million CNY | 0.09% |
| 2018 | 130.92 Million CNY | 1.98% |
| 2017 | 128.37 Million CNY | 32.53% |
| 2016 | 96.87 Million CNY | 20.17% |
| 2015 | 80.61 Million CNY | 21.41% |
| 2014 | 66.39 Million CNY | 4.12% |
| 2013 | 63.77 Million CNY | 24.84% |
| 2012 | 51.08 Million CNY | -13.18% |
| 2011 | 58.83 Million CNY | 20.38% |
| 2010 | 48.87 Million CNY | 7.05% |
| 2009 | 45.65 Million CNY | 31.02% |
| 2008 | 34.84 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 116.57 Million CNY | -15.94% |
| 2024 Q1 | 127.56 Million CNY | 5.57% |
| 2024 Q2 | 138.69 Million CNY | 8.72% |
| 2023 Q2 | 123.19 Million CNY | 4.71% |
| 2023 Q1 | 117.65 Million CNY | 13.94% |
| 2023 Q4 | 120.83 Million CNY | -1.24% |
| 2023 FY | 120.83 Million CNY | 17.02% |
| 2023 Q3 | 122.34 Million CNY | -0.69% |
| 2022 Q4 | 103.25 Million CNY | -5.89% |
| 2022 FY | 103.25 Million CNY | -4.73% |
| 2022 Q2 | 121.98 Million CNY | 4.41% |
| 2022 Q3 | 109.72 Million CNY | -10.05% |
| 2022 Q1 | 116.83 Million CNY | 7.79% |
| 2021 Q3 | 128.79 Million CNY | -3.63% |
| 2021 Q4 | 108.38 Million CNY | -15.85% |
| 2021 Q2 | 133.64 Million CNY | 4.26% |
| 2021 FY | 108.38 Million CNY | -11.48% |
| 2021 Q1 | 128.18 Million CNY | 4.69% |
| 2020 Q3 | 137.04 Million CNY | -7.08% |
| 2020 Q1 | 134.4 Million CNY | 2.57% |
| 2020 Q2 | 147.49 Million CNY | 9.74% |
| 2020 Q4 | 122.43 Million CNY | -10.66% |
| 2020 FY | 122.43 Million CNY | -6.56% |
| 2019 Q1 | 120.44 Million CNY | -8.0% |
| 2019 FY | 131.03 Million CNY | 0.09% |
| 2019 Q2 | 140.28 Million CNY | 16.47% |
| 2019 Q4 | 131.03 Million CNY | -9.27% |
| 2019 Q3 | 144.42 Million CNY | 2.95% |
| 2018 Q3 | 103.57 Million CNY | -9.49% |
| 2018 FY | 130.92 Million CNY | 1.98% |
| 2018 Q2 | 114.44 Million CNY | 24.44% |
| 2018 Q4 | 130.92 Million CNY | 26.4% |
| 2018 Q1 | 91.96 Million CNY | -28.36% |
| 2017 Q4 | 128.37 Million CNY | -14.95% |
| 2017 FY | 128.37 Million CNY | 32.53% |
| 2017 Q1 | 95.69 Million CNY | -1.21% |
| 2017 Q2 | 118.84 Million CNY | 24.19% |
| 2017 Q3 | 150.94 Million CNY | 27.01% |
| 2016 Q1 | 78.9 Million CNY | -2.12% |
| 2016 FY | 96.87 Million CNY | 20.17% |
| 2016 Q4 | 96.87 Million CNY | 4.16% |
| 2016 Q3 | 93 Million CNY | -3.32% |
| 2016 Q2 | 96.2 Million CNY | 21.93% |
| 2015 Q2 | 69.13 Million CNY | 10.71% |
| 2015 Q3 | 70.46 Million CNY | 1.92% |
| 2015 Q4 | 80.61 Million CNY | 14.4% |
| 2015 FY | 80.61 Million CNY | 21.41% |
| 2015 Q1 | 62.44 Million CNY | -5.95% |
| 2014 Q3 | 66.3 Million CNY | -1.0% |
| 2014 Q2 | 66.97 Million CNY | -1.84% |
| 2014 Q1 | 68.22 Million CNY | 6.99% |
| 2014 FY | 66.39 Million CNY | 4.12% |
| 2014 Q4 | 66.39 Million CNY | 0.14% |
| 2013 Q1 | 43.08 Million CNY | -15.64% |
| 2013 Q3 | 44.83 Million CNY | -2.57% |
| 2013 Q4 | 63.77 Million CNY | 42.24% |
| 2013 FY | 63.77 Million CNY | 24.84% |
| 2013 Q2 | 46.01 Million CNY | 6.8% |
| 2012 Q3 | 62.03 Million CNY | 4.57% |
| 2012 FY | 51.08 Million CNY | -13.18% |
| 2012 Q2 | 59.32 Million CNY | 30.23% |
| 2012 Q1 | 45.55 Million CNY | -22.57% |
| 2012 Q4 | 51.08 Million CNY | -17.66% |
| 2011 Q4 | 58.83 Million CNY | 0.97% |
| 2011 Q2 | 58.39 Million CNY | 0.0% |
| 2011 Q3 | 58.26 Million CNY | -0.22% |
| 2011 FY | 58.83 Million CNY | 20.38% |
| 2010 FY | 48.87 Million CNY | 7.05% |
| 2010 Q4 | 48.87 Million CNY | 0.0% |
| 2009 FY | 45.65 Million CNY | 31.02% |
| 2008 FY | 34.84 Million CNY | 0.0% |